Sign inJoin waitlistJoin the waitlist

SL

Steven Larosa

Infectious Disease

Credentials: · · · ·

History

Massachusetts General Hospital
1995–1997
Cleveland Clinic Fdntn
1992–1995
Boston University School of Medicine
1988–1992

Research

Efficacy and safety of recombinant human activated protein C for severe sepsis
New England Journal of Medicine · 2001 · 4,153 citations
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial
JAMA · 2013 · 671 citations
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and…
Critical Care Medicine · 2013 · 242 citations

SO
Steven Opal
14 papers
Andre Kalil
5 papers
Gordon Bernard
4 papers
KT
Kenneth Tomecki
3 papers
Mark Tidswell
3 papers
Dennis Maki
2 papers
Derek Angus
2 papers
GK
Gary Kinasewitz
2 papers
JM
Jeffrey Martin
2 papers
Michael Peluso
2 papers
Richard Wunderink
2 papers
Roland Schein
2 papers